Format

Send to

Choose Destination
J Med Chem. 2002 Jan 17;45(2):492-503.

4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.

Author information

1
Merck Sharp and Dohme, The Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, UK. stephen_fletcher@merck.com

Abstract

On the basis of a spirocyclic ether screening lead, a series of acyclic sulfones have been identified as high-affinity, selective 5-HT(2A) receptor antagonists. Bioavailability lacking in the parent, 1-(2-(2,4-difluorophenyl)ethyl)-4-(phenylsulfonyl)piperidine (12), was introduced by using stability toward rat liver microsomes as a predictor of bioavailability. By this means, the 4-cyano- and 4-carboxamidophenylsulfonyl derivatives 26 and 31 were identified as orally bioavailable, brain-penetrant analogues suitable for evaluation in animal models. Bioavailability was also attainable by N substitution leading to the N-phenacyl derivative 35. IKr activity detected through counterscreening was reduced to insignificant levels in vivo with the latter compound.

PMID:
11784153
DOI:
10.1021/jm011030v
[Indexed for MEDLINE]

MeSH terms, Substances

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Chemical Information

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center